email   Email Us: info@lupinepublishers.com phone   Call Us: +1 (914) 407-6109   57 West 57th Street, 3rd floor, New York - NY 10019, USA

Lupine Publishers Group

Lupine Publishers

ISSN: 2637-6636

Interventions in Pediatric Dentistry: Open Access Journal

Mini Review(ISSN: 2637-6636)

Epidemiology and Control of Lassa fever

Volume 1 - Issue 4

Effiong E Bassey*

  • Author Information Open or Close
    • Department of Applied Microbiology and Brewing, Nnamdi Azikiwe University, Nigeria

    *Corresponding author: Effiong E Bassey Department of Applied Microbiology and Brewing, Nnamdi Azikiwe University, Awka, Nigeria

Received: April 20, 2018;   Published: May 01, 2018

DOI: 10.32474/IPDOAJ.2018.01.000116

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

The Lassa Virus (an Arenavirus) is found in West Africa, where it sometimes a severe hemorrhage illness called Lassa fever. The antivirus drug ribavirin is effective, but only if administered early in the course of illness. Because of its expense, need for intravenous administration, potential toxicity, and teratogenicity, empiric therapy with ribavirin is undesirable. Laboratory diagnosis of acute Lassa virus infection has traditionally employed the indirect fluorescent-antibody (IFA) test. However, enzymelinked immunosorbent assays (ELISAs) for Lassa virus antigen and immunoglobin M (IgM and IgG) antibodies have been developed that are thought to be more sensitive and specific likely represent underestimates with. The high sensitive and specificity, capability for early diagnosis, and prognostic value of the ELISAs make them the diagnostic tests of choice for detection of Lassa fever.

Keywords: Epidemiology; Control; Lassa Fever

Abstract| Introduction| Epidemiology| Prevention and Control| Conclusion| References|

Close

Online Submission System

Drag and drop files here

or

Browse Files
( For multiple files submission, zip them in a single file to submit. For file zipping software Download )